Axin Antikörper (C-Term)
Kurzübersicht für Axin Antikörper (C-Term) (ABIN1732155)
Target
Alle Axin (AXIN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - C-Term
 - 
                                            
Spezifität
 - Reacts with human AXIN1
 - 
                                            
Aufreinigung
 - Antigen affinity purified
 - 
                                            
Immunogen
 - 14 amino acid peptide near the carboxy terminus of human AXIN1
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        
Working dilution: IHC - P (5 μg/mL), WB (1 - 2 μg/mL)
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 1 mg/mL
 - 
                                            
Buffer
 - PBS, Sodium azide 0.02 %
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C/-20 °C
 - 
                                            
Informationen zur Lagerung
 - Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
 
 - 
                                            
 - 
    
- Axin (AXIN1) (Axin 1 (AXIN1))
 - 
                                            
Andere Bezeichnung
 - AXIN1
 - 
                                            
Hintergrund
 - Component of the beta-catenin destruction complex required for regulating CTNNB1 levels through phosphorylation and ubiquitination, and modulating Wnt-signaling. Controls dorsoventral patterning via two opposing effects, down-regulates CTNNB1 to inhibit the Wnt signaling pathway and ventralize embryos, but also dorsalizes embryos by activating a Wnt-independent JNK signaling pathway.
 - 
                                            
UniProt
 - O15169
 - 
                                            
Pathways
 - WNT Signalweg, Sensory Perception of Sound, Regulation of G-Protein Coupled Receptor Protein Signaling
 
Target
 -